Gennex Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Gennex Laboratories has a total shareholder equity of ₹927.2M and total debt of ₹218.7M, which brings its debt-to-equity ratio to 23.6%. Its total assets and total liabilities are ₹1.3B and ₹395.4M respectively. Gennex Laboratories's EBIT is ₹119.3M making its interest coverage ratio 38.2. It has cash and short-term investments of ₹97.7M.
Key information
23.6%
Debt to equity ratio
₹218.65m
Debt
Interest coverage ratio | 38.2x |
Cash | ₹97.73m |
Equity | ₹927.15m |
Total liabilities | ₹395.40m |
Total assets | ₹1.32b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531739's short term assets (₹649.7M) exceed its short term liabilities (₹230.2M).
Long Term Liabilities: 531739's short term assets (₹649.7M) exceed its long term liabilities (₹165.2M).
Debt to Equity History and Analysis
Debt Level: 531739's net debt to equity ratio (13%) is considered satisfactory.
Reducing Debt: 531739's debt to equity ratio has increased from 6% to 23.6% over the past 5 years.
Debt Coverage: 531739's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 531739's interest payments on its debt are well covered by EBIT (38.2x coverage).